SG Americas Securities LLC Purchases Shares of 20,995 Liquidia Co. (NASDAQ:LQDA)

SG Americas Securities LLC purchased a new stake in shares of Liquidia Co. (NASDAQ:LQDA) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 20,995 shares of the company’s stock, valued at approximately $210,000.

Several other hedge funds have also bought and sold shares of the stock. Whitcomb & Hess Inc. grew its holdings in Liquidia by 10.2% during the third quarter. Whitcomb & Hess Inc. now owns 11,599 shares of the company’s stock valued at $116,000 after purchasing an additional 1,074 shares during the period. Bluefin Capital Management LLC bought a new stake in Liquidia during the second quarter valued at about $277,000. The Manufacturers Life Insurance Company grew its holdings in Liquidia by 25.2% during the second quarter. The Manufacturers Life Insurance Company now owns 22,706 shares of the company’s stock valued at $272,000 after purchasing an additional 4,572 shares during the period. Squarepoint Ops LLC grew its holdings in Liquidia by 53.4% during the second quarter. Squarepoint Ops LLC now owns 82,272 shares of the company’s stock valued at $987,000 after purchasing an additional 28,638 shares during the period. Finally, Marshall Wace LLP bought a new stake in Liquidia during the second quarter valued at about $545,000. Institutional investors own 64.54% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on LQDA shares. Raymond James upgraded Liquidia from an “outperform” rating to a “strong-buy” rating in a research report on Monday, August 19th. HC Wainwright lowered their price objective on Liquidia from $32.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, August 20th. Needham & Company LLC restated a “buy” rating and issued a $25.00 price objective on shares of Liquidia in a research report on Monday, August 19th. Oppenheimer started coverage on Liquidia in a research report on Tuesday, June 25th. They issued a “market perform” rating on the stock. Finally, Bank of America lowered their price objective on Liquidia from $24.00 to $23.00 and set a “buy” rating on the stock in a research report on Tuesday, August 20th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, six have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $24.67.

Insiders Place Their Bets

In other Liquidia news, insider Rajeev Saggar sold 2,260 shares of the business’s stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $11.11, for a total transaction of $25,108.60. Following the sale, the insider now directly owns 207,383 shares of the company’s stock, valued at $2,304,025.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Liquidia news, CEO Roger Jeffs sold 8,053 shares of the business’s stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $11.11, for a total transaction of $89,468.83. Following the sale, the chief executive officer now directly owns 812,193 shares of the company’s stock, valued at $9,023,464.23. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Rajeev Saggar sold 2,260 shares of the business’s stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $11.11, for a total value of $25,108.60. Following the sale, the insider now directly owns 207,383 shares in the company, valued at $2,304,025.13. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 23,384 shares of company stock valued at $256,990 over the last ninety days. 31.60% of the stock is owned by insiders.

Liquidia Trading Up 1.0 %

NASDAQ:LQDA opened at $11.20 on Wednesday. The company has a market capitalization of $855.84 million, a P/E ratio of -7.18 and a beta of 0.22. Liquidia Co. has a 12 month low of $6.04 and a 12 month high of $16.99. The business’s 50-day moving average is $10.35 and its 200 day moving average is $11.83.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.37) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.02). Liquidia had a negative return on equity of 183.57% and a negative net margin of 755.46%. The company had revenue of $3.66 million for the quarter, compared to the consensus estimate of $7.92 million. On average, research analysts forecast that Liquidia Co. will post -1.69 earnings per share for the current year.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).